Susan Burdette-Radoux

Randomized Phase II Study of Cilengitide, an Integrin-Targeting Arginine-Glycine-Aspartic Acid Peptide, in Recurrent Glioblastoma Multiforme

David A. Reardon, Karen Fink, Tom Mikkelsen et al. · Journal of Clinical Oncology · 2008 · 473 citations · Full text

Medicine, Oncology, Pharmacology +16

Selection of Tumor-binding Ligands in Cancer Patients with Phage Display Libraries

David N. Krag, Girja S. Shukla, Guang‐Ping Shen et al. · Cancer Research · 2006 · 209 citations

Medicine, Cancer Biology, Oncology +15

An open randomised trial of second-line endocrine therapy in advanced breast cancer

Carsten Rose, O. Vtoraya, A Płużańska et al. · European Journal of Cancer · 2003 · 192 citations

Medicine, Endocrinology, Oncology +13

Randomized, double-blind, placebo-controlled trial comparing the response rates of carmustine, dacarbazine, and cisplatin with and without tamoxifen in patients with metastatic melanoma. National Cancer Institute of Canada Clinical Trials Group.

James J. Rusthoven, Ian Quirt, N. Iscoe et al. · Journal of Clinical Oncology · 1996 · 167 citations

Medicine, Oncology, Pharmacology +9

Epoetin Alfa Therapy Increases Hemoglobin Levels and Improves Quality of Life in Patients With Cancer-Related Anemia Who Are Not Receiving Chemotherapy and Patients With Anemia Who Are Receiving Chemotherapy

Ian Quirt, Christine Robeson, Catherine Y. Lau et al. · Journal of Clinical Oncology · 2001 · 151 citations

Medicine, Oncology, Pharmacology +10